Global Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Prostate Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Biological Therapy
1.3.3 Chemotherapy
1.4 Market by Application
1.4.1 Global Prostate Cancer Treatment Market Share by Application: 2020 VS 2026
1.4.2 Hospital
1.4.3 Research Institution
1.4.4 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Treatment Market Perspective (2015-2026)
2.2 Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Prostate Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Prostate Cancer Treatment Industry Dynamic
2.3.1 Prostate Cancer Treatment Market Trends
2.3.2 Prostate Cancer Treatment Market Drivers
2.3.3 Prostate Cancer Treatment Market Challenges
2.3.4 Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Treatment Players by Market Size
3.1.1 Global Top Prostate Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Treatment Revenue
3.4 Global Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Revenue in 2019
3.5 Key Players Prostate Cancer Treatment Area Served
3.6 Key Players Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Prostate Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Prostate Cancer Treatment Historic Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Treatment Market Size (2015-2026)
6.2 North America Prostate Cancer Treatment Market Size by Type (2015-2020)
6.3 North America Prostate Cancer Treatment Market Size by Application (2015-2020)
6.4 North America Prostate Cancer Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Prostate Cancer Treatment Market Size (2015-2026)
7.2 Europe Prostate Cancer Treatment Market Size by Type (2015-2020)
7.3 Europe Prostate Cancer Treatment Market Size by Application (2015-2020)
7.4 Europe Prostate Cancer Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Treatment Market Size (2015-2026)
8.2 Asia-Pacific Prostate Cancer Treatment Market Size by Type (2015-2020)
8.3 Asia-Pacific Prostate Cancer Treatment Market Size by Application (2015-2020)
8.4 Asia-Pacific Prostate Cancer Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Prostate Cancer Treatment Market Size (2015-2026)
9.2 Latin America Prostate Cancer Treatment Market Size by Type (2015-2020)
9.3 Latin America Prostate Cancer Treatment Market Size by Application (2015-2020)
9.4 Latin America Prostate Cancer Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Treatment Market Size (2015-2026)
10.2 Middle East & Africa Prostate Cancer Treatment Market Size by Type (2015-2020)
10.3 Middle East & Africa Prostate Cancer Treatment Market Size by Application (2015-2020)
10.4 Middle East & Africa Prostate Cancer Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Tolmar
11.1.1 Tolmar Company Details
11.1.2 Tolmar Business Overview
11.1.3 Tolmar Prostate Cancer Treatment Introduction
11.1.4 Tolmar Revenue in Prostate Cancer Treatment Business (2015-2020))
11.1.5 Tolmar Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Prostate Cancer Treatment Introduction
11.2.4 Astellas Pharma Revenue in Prostate Cancer Treatment Business (2015-2020)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Prostate Cancer Treatment Introduction
11.3.4 AstraZeneca Revenue in Prostate Cancer Treatment Business (2015-2020)
11.3.5 AstraZeneca Recent Development
11.4 Ferring Pharmaceuticals
11.4.1 Ferring Pharmaceuticals Company Details
11.4.2 Ferring Pharmaceuticals Business Overview
11.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Introduction
11.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2015-2020)
11.4.5 Ferring Pharmaceuticals Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2015-2020)
11.5.5 Johnson & Johnson Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Prostate Cancer Treatment Introduction
11.6.4 Abbott Revenue in Prostate Cancer Treatment Business (2015-2020)
11.6.5 Abbott Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Prostate Cancer Treatment Introduction
11.7.4 Sanofi Revenue in Prostate Cancer Treatment Business (2015-2020)
11.7.5 Sanofi Recent Development
11.8 Ipsen
11.8.1 Ipsen Company Details
11.8.2 Ipsen Business Overview
11.8.3 Ipsen Prostate Cancer Treatment Introduction
11.8.4 Ipsen Revenue in Prostate Cancer Treatment Business (2015-2020)
11.8.5 Ipsen Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Prostate Cancer Treatment Introduction
11.9.4 Novartis Revenue in Prostate Cancer Treatment Business (2015-2020)
11.9.5 Novartis Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Prostate Cancer Treatment Introduction
11.10.4 Bayer Revenue in Prostate Cancer Treatment Business (2015-2020)
11.10.5 Bayer Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Biological Therapy
Table 3. Key Players of Chemotherapy
Table 4. Global Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Prostate Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Prostate Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Prostate Cancer Treatment Market Share by Regions (2015-2020)
Table 8. Global Prostate Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Prostate Cancer Treatment Market Share by Regions (2021-2026)
Table 10. Prostate Cancer Treatment Market Market Trends
Table 11. Prostate Cancer Treatment Market Drivers
Table 12. Prostate Cancer Treatment Market Challenges
Table 13. Prostate Cancer Treatment Market Restraints
Table 14. Global Prostate Cancer Treatment Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Prostate Cancer Treatment Market Share by Players (2015-2020)
Table 16. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2019)
Table 17. Global Prostate Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Prostate Cancer Treatment Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Prostate Cancer Treatment Revenue Market Share by Type (2015-2020)
Table 23. Global Prostate Cancer Treatment Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Prostate Cancer Treatment Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Prostate Cancer Treatment Revenue Market Share by Application (2015-2020)
Table 26. Global Prostate Cancer Treatment Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 29. North America Prostate Cancer Treatment Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 31. North America Prostate Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Prostate Cancer Treatment Market Share by Country (2015-2020)
Table 33. Europe Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 35. Europe Prostate Cancer Treatment Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 37. Europe Prostate Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Prostate Cancer Treatment Market Share by Country (2015-2020)
Table 39. Asia-Pacific Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 41. Asia-Pacific Prostate Cancer Treatment Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 43. Asia-Pacific Prostate Cancer Treatment Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Prostate Cancer Treatment Market Share by Region (2015-2020)
Table 45. Latin America Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 47. Latin America Prostate Cancer Treatment Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 49. Latin America Prostate Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Prostate Cancer Treatment Market Share by Country (2015-2020)
Table 51. Middle East & Africa Prostate Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Prostate Cancer Treatment Market Share by Type (2015-2020)
Table 53. Middle East & Africa Prostate Cancer Treatment Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Prostate Cancer Treatment Market Share by Application (2015-2020)
Table 55. Middle East & Africa Prostate Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Prostate Cancer Treatment Market Share by Country (2015-2020)
Table 57. Tolmar Company Details
Table 58. Tolmar Business Overview
Table 59. Tolmar Prostate Cancer Treatment Product
Table 60. Tolmar Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 61. Tolmar Recent Development
Table 62. Astellas Pharma Company Details
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Prostate Cancer Treatment Product
Table 65. Astellas Pharma Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 66. Astellas Pharma Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Prostate Cancer Treatment Product
Table 70. AstraZeneca Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Ferring Pharmaceuticals Company Details
Table 73. Ferring Pharmaceuticals Business Overview
Table 74. Ferring Pharmaceuticals Prostate Cancer Treatment Product
Table 75. Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 76. Ferring Pharmaceuticals Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Prostate Cancer Treatment Product
Table 80. Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Prostate Cancer Treatment Product
Table 85. Abbott Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 86. Abbott Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Prostate Cancer Treatment Product
Table 90. Sanofi Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Ipsen Business Overview
Table 93. Ipsen Prostate Cancer Treatment Product
Table 94. Ipsen Company Details
Table 95. Ipsen Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 96. Ipsen Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Prostate Cancer Treatment Product
Table 100. Novartis Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 101. Novartis Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Prostate Cancer Treatment Product
Table 105. Bayer Revenue in Prostate Cancer Treatment Business (2015-2020) (US$ Million)
Table 106. Bayer Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Prostate Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Biological Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Prostate Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research Institution Case Studies
Figure 7. Clinic Case Studies
Figure 8. Prostate Cancer Treatment Report Years Considered
Figure 9. Global Prostate Cancer Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Prostate Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate Cancer Treatment Market Share by Regions (2021-2026)
Figure 12. Global Prostate Cancer Treatment Market Share by Players in 2019
Figure 13. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Revenue in 2019
Figure 15. North America Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Prostate Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Tolmar Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 41. Astellas Pharma Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 42. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 43. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 44. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 45. Abbott Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 46. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 47. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 48. Novartis Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 49. Bayer Revenue Growth Rate in Prostate Cancer Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed